Characterization of the T-cell receptor beta chain repertoire in tumor-infiltrating lymphocytes

Cancer Medicine

Volumn 5, Issue 9, 2016, Pages 2513-2521

  Nakanishi, Katsumi ^a   Kukita, Yoji ^a   Segawa, Hidenobu ^a   Inoue, Norimitsu ^a   Ohue, Masayuki ^a   Kato, Kikuya ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Barcode sequences; colorectal cancer; next generation sequencing; T cell receptor; Tumor infiltrating lymphocytes

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CANCER; COMPLEMENTARITY DETERMINING REGION; COMPLEMENTARITY DETERMINING REGION 3; CONTROLLED STUDY; DNA BARCODING; DNA SEQUENCE; GENOME SIZE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; TUMOR ASSOCIATED LEUKOCYTE;

EID: 84991065403     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.828     Document Type: Article

References (32)

1. Fridman, W. H., F. Pages, C. Sautes-Fridman, and J. Galon. 2012. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 12:298–306.
2. deLeeuw, R. J., S. E. Kost, J. A. Kakal, and B. H. Nelson. 2012. The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin. Cancer Res. 18:3022–3029.
3. Galon, J., A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pages, et al. 2006. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–1964.
4. Coulie, P. G., B. J. Van den Eynde, P. van der Bruggen, and T. Boon. 2014. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat. Rev. Cancer 14:135–146.
5. Dudley, M. E., and S. A. Rosenberg. 2003. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. Cancer 3:666–675.
6. Pardoll, D. M. 2012. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12:252–264.
7. Smith-Garvin, J. E., G. A. Koretzky, and M. S. Jordan. 2009. T cell activation. Annu. Rev. Immunol. 27:591–619.
8. Nguyen, P., J. Ma, D. Pei, C. Obert, C. Cheng, and T. L. Geiger. 2011. Identification of errors introduced during high throughput sequencing of the T cell receptor repertoire. BMC Genomics 12:106.
9. Qi, Q., Y. Liu, Y. Cheng, J. Glanville, D. Zhang, J. Y. Lee, et al. 2014. Diversity and clonal selection in the human T-cell repertoire. Proc. Natl. Acad. Sci. USA 111:13139–13144.
10. Robins, H. S., P. V. Campregher, S. K. Srivastava, A. Wacher, C. J. Turtle, O. Kahsai, et al. 2009. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 114:4099–4107.
11. Zvyagin, I. V., M. V. Pogorelyy, M. E. Ivanova, E. A. Komech, M. Shugay, D. A. Bolotin, et al. 2014. Distinctive properties of identical twins' TCR repertoires revealed by high-throughput sequencing. Proc. Natl. Acad. Sci. USA 111:5980–5985.
12. Kukita, Y., R. Matoba, J. Uchida, T. Hamakawa, Y. Doki, F. Imamura, et al. 2015. High-fidelity target sequencing of individual molecules identified using barcode sequences: de novo detection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients. DNA Res. 22:269–277.
13. Warren, R. L., J. D. Freeman, T. Zeng, G. Choe, S. Munro, R. Moore, et al. 2011. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res. 21:790–797.
14. Edgar, R. C. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32:1792–1797.
15. Lloyd, S., and Q. O. Snell. 2011. Accelerated large-scale multiple sequence alignment. BMC Bioinformatics 12:466.
16. Kent, W. J. 2002. BLAT–the BLAST-like alignment tool. Genome Res. 12:656–664.
17. Shugay, M., O. V. Britanova, E. M. Merzlyak, M. A. Turchaninova, I. Z. Mamedov, T. R. Tuganbaev, et al. 2014. Towards error-free profiling of immune repertoires. Nat. Methods 11:653–655.
18. Vollmers, C., R. V. Sit, J. A. Weinstein, C. L. Dekker, and S. R. Quake. 2013. Genetic measurement of memory B-cell recall using antibody repertoire sequencing. Proc. Natl. Acad. Sci. USA 110:13463–13468.
19. Hughes, J. B., J. J. Hellmann, T. H. Ricketts, and B. J. Bohannan. 2001. Counting the uncountable: statistical approaches to estimating microbial diversity. Appl. Environ. Microbiol. 67:4399–4406.
20. Meresse, B., S. A. Curran, C. Ciszewski, G. Orbelyan, M. Setty, G. Bhagat, et al. 2006. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203:1343–1355.
21. Calis, J. J., and B. R. Rosenberg. 2014. Characterizing immune repertoires by high throughput sequencing: strategies and applications. Trends Immunol. 35:581–590.
22. Sherwood, A. M., R. O. Emerson, D. Scherer, N. Habermann, K. Buck, J. Staffa, et al. 2013. Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue. Cancer Immunol. Immunother. 62:1453–1461.
23. Emerson, R. O., A. M. Sherwood, M. J. Rieder, J. Guenthoer, D. W. Williamson, C. S. Carlson, et al. 2013. High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer. J. Pathol. 231:433–440.
24. Lim, A., L. Trautmann, M. A. Peyrat, C. Couedel, F. Davodeau, F. Romagne, et al. 2000. Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire. J. Immunol. 165:2001–2011.
25. Price, D. A., J. M. Brenchley, L. E. Ruff, M. R. Betts, B. J. Hill, M. Roederer, et al. 2005. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 202:1349–1361.
26. Trautmann, L., M. Rimbert, K. Echasserieau, X. Saulquin, B. Neveu, J. Dechanet, et al. 2005. Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses. J. Immunol. 175:6123–6132.
27. Madi, A., E. Shifrut, S. Reich-Zeliger, H. Gal, K. Best, W. Ndifon, et al. 2014. T-cell receptor repertoires share a restricted set of public and abundant CDR3 sequences that are associated with self-related immunity. Genome Res. 24:1603–1612.
28. Cha, E., M. Klinger, Y. Hou, C. Cummings, A. Ribas, M. Faham, et al. 2014. Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients. Sci. Transl. Med. 6:238ra70.
29. Snyder, A., V. Makarov, T. Merghoub, J. Yuan, J. M. Zaretsky, A. Desrichard, et al. 2014. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371:2189–2199.
30. Robins, H. S., S. K. Srivastava, P. V. Campregher, C. J. Turtle, J. Andriesen, S. R. Riddell, et al. 2010. Overlap and effective size of the human CD8+ T cell receptor repertoire. Sci. Transl. Med. 2:47ra64.
31. Huseby, E. S., J. White, F. Crawford, T. Vass, D. Becker, C. Pinilla, et al. 2005. How the T cell repertoire becomes peptide and MHC specific. Cell 122:247–260.
32. Rudolph, M. G., R. L. Stanfield, and I. A. Wilson. 2006. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24:419–466.